Goldman Sachs

FinanceNov 12
Goldman Sachs Expects Fed Rate Hike in March 2027Goldman Sachs has revised its forecast for U.S. monetary policy following the release of October inflation data. The bank now anticipates an additional Fed rate hike in March 2027 and a reduction starting only in December. Previously, analysts had predicted a shift to easing three months earlier.

CryptocurrencyNov 10
Goldman Sachs CEO Reports High Demand for AI Infrastructure FinancingGoldman Sachs CEO David Solomon believes that interest in financing artificial intelligence infrastructure remains high despite the decline in tech stocks. The bank continues to participate in major deals, including preparations for a potential IPO of Anthropic.

EconomicsOct 30
Goldman Sachs Reports Long-Term Consequences of AI-Related LayoffsGoldman Sachs compared the first workers who lost their jobs due to AI to victims of past waves of automation. They take about a month longer to find new employment and are 10 percentage points more likely to remain unemployed a year later. Workers aged 35 and older face the most challenges.

FinanceOct 26
Goldman Sachs Names Yen as Best Hedge Against AI CrisisAccording to Goldman Sachs, the Japanese yen is currently the best hedge against market risks related to artificial intelligence and will prove resilient to future shocks.

EconomicsOct 20
Goldman Sachs: Delays in Energy Infrastructure Will Slow AI Data Center GrowthGoldman Sachs warns that issues with energy infrastructure could negatively impact progress in AI and lead to regulatory measures.

FinanceOct 18
Market Volatility Creates Opportunities in AI Assets and Municipal BondsGoldman Sachs sees investment opportunities in debt instruments due to market volatility and the resilience of credit markets.

FinanceOct 14
Goldman Sachs Revenue Increased by 72% in Q3Goldman Sachs' revenue from trading stocks rose by 72% in Q3, while JPMorgan Chase fell short of expectations.

FinanceOct 07
Goldman Sachs: Chinese Biotechnology Attracts Attention from Major Pharmaceutical CompaniesGoldman Sachs reports that pharmaceutical companies are turning to Chinese biotechnology due to patent expirations.

FinanceOct 07
S&P 500 Rises by 18.3% While Goldman Sachs Non-AI Index Gains Only 6.7%The S&P 500 index rose by 18.3%, while the Goldman Sachs non-AI index gained only 6.7%. The increases are driven by the growth of chip company stocks.

FinanceOct 01
Goldman Sachs Moves Forecast for Second Fed Rate Hike to DecemberGoldman Sachs adjusted its forecast for the second Fed rate hike from October to December amid declining core PCE inflation.

